SCHEMBL24867288

SCHEMBL24867288

Cc1cc(C)cc(-c2cnc(Nc3ccc(CC(C)C)cc3)nc2)c1

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.37
POLB P06746 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
SYK P43405 4/20 0.37
HDAC3 O15379 2/20 0.37
HDAC1 Q13547 2/20 0.37
HDAC2 Q92769 2/20 0.37
HDAC6 Q9UBN7 2/20 0.37
RAB9A P51151 2/20 0.36
NPC1 O15118 1/20 0.36
CCNA2 P20248 1/20 0.35
CDK2 P24941 1/20 0.35
CDK5 Q00535 1/20 0.35
CDK5R1 Q15078 1/20 0.35
CSNK2A1 P68400 1/20 0.35
AURKA O14965 2/20 0.35
MAPK1 P28482 1/20 0.35
ALDH1A1 P00352 1/20 0.34
RORC P51449 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24867287 0.88 ACACB (0.39) KDM4EPOLBSMN1; SMN2CCNA2CDK2
SCHEMBL24867238 0.88 PANK3 (0.38) SYK
SCHEMBL24867262 0.88 RAB9A (0.44) KDM4EPOLBSMN1; SMN2RAB9ANPC1
SCHEMBL24867269 0.87 HDAC3 (0.43) KDM4ESMN1; SMN2HDAC3HDAC1HDAC2
SCHEMBL24867268 0.83 CHEK1 (0.49) SYKRAB9ACSNK2A1MAPK1RORC
SCHEMBL24867240 0.82 BRAF (0.42) RAB9ACSNK2A1MAPK1
SCHEMBL30130213 0.81 SYK (0.40) SYKRAB9AMAPK1
SCHEMBL30130219 0.81 SYK (0.40) SYKRAB9AMAPK1
SCHEMBL24867276 0.80 RAB9A (0.46) SYKHDAC3HDAC1HDAC2HDAC6
SCHEMBL24867254 0.80 CSNK2A1 (0.40) SMN1; SMN2HDAC3HDAC1HDAC2HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023283488-A9 CDK19-SELECTIVE INHIBITORS, AND METHODS OF USE THEREOF CZ BIOHUB SF, LLC (US) 2023-05-25 WO disclosed
WO-2023283488-A2 CDK19-SELECTIVE INHIBITORS, AND METHODS OF USE THEREOF CHAN ZUCKERBERG BIOHUB, INC. (US) 2023-01-12 WO disclosed